CANNAPHARMARX, INC. (CPMD) Net income 2016–2025
CANNAPHARMARX, INC. (CPMD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.1MFY2025 · since FY2016: -$1.0M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | -12.4% |
| FY2024 | -$9.9M | -368.6% |
| FY2023 | $3.7M | +143.2% |
| FY2022 | -$8.5M | +3.4% |
| FY2021 | -$8.8M | +55.6% |
| FY2020 | -$19.9M | +2.7% |
| FY2019 | -$20.5M | -560.9% |
| FY2018 | -$3.1M | -46550.2% |
| FY2017 | -$6,633 | +99.3% |
| FY2016 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CPMD financial trends
CPMD RevenueCPMD Net marginCPMD Gross profitCPMD Gross marginCPMD Operating incomeCPMD Operating marginCPMD Operating cash flowCPMD Free cash flowCPMD Capital expendituresCPMD Return on equityCPMD Stock buybacksCPMD Dividends paidCPMD Total assetsCPMD Total liabilitiesCPMD Shareholders’ equityCPMD overview →